News + Filings Transactions
|
Sinha Vikas
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/03/2023 | Allovir, Inc. | ALVR | Sale | Common Stock | 755 | $1.98 | $1.5k | | 10/03/2023 |
| 08/17/2023 | Allovir, Inc. | ALVR | Sale | Common Stock | 10.5k | $2.50 | $26.2k | | 08/17/2023 |
| 07/05/2023 | Allovir, Inc. | ALVR | Sale | Common Stock | 3k | $3.05 | $9.1k | | 07/05/2023 |
| 01/20/2023 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.4k | $5.14 | $7.3k | | 01/19/2023 |
| 01/19/2023 | Allovir, Inc. | ALVR | Sale | Common Stock | 5.1k | $5.08 | $26k | | 01/19/2023 |
| 08/16/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 100k | $0.00 | $0 | | 08/16/2022 |
| 07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 3.3M | $4.61 | $15M | By ElevateBio LLC | 07/28/2022 |
| 07/20/2022 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.4k | $5.21 | $7.5k | | 07/20/2022 |
| 07/01/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 29.4k | $0.00 | $0 | | 07/01/2022 |
| 07/01/2022 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 54.6k | $4.13 | $225.5k | | 07/01/2022 |
| 04/28/2022 | Verona Pharma plc | VRNA | Grant | Share Options (Right to Buy) | 200k | $0.00 | $0 | | 04/28/2022 |
| 04/20/2022 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.2k | $6.68 | $7.8k | | 04/20/2022 |
| 01/20/2022 | Allovir, Inc. | ALVR | Sale | Common Stock | 6.4k | $8.75 | $56.5k | | 01/20/2022 |
| 01/18/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 48.8k | $0.00 | $0 | | 01/18/2022 |
| 01/18/2022 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 119.2k | $9.15 | $1.1M | | 01/18/2022 |
| 08/09/2021 | Verona Pharma plc | VRNA | Grant | Share Options (Right to Buy) | 64k | $0.00 | $0 | | 08/09/2021 |
| 05/04/2021 | Verona Pharma plc | VRNA | Sale | | 10k | $0.84 | $8.4k | | 05/04/2021 |
| 02/01/2021 | Verona Pharma plc | VRNA | Sale | | 10.2k | $0.99 | $10.2k | | 02/01/2021 |
| 01/19/2021 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 109.2k | $42.15 | $4.6M | | 01/19/2021 |
| 01/19/2021 | Allovir, Inc. | ALVR | Grant | Common Stock | 58.8k | $0.00 | $0 | | 01/19/2021 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Series A-2 Convertible Preferred Stock | 20M | $0.00 | $0 | See Footnote | 08/03/2020 |
| 08/03/2020 | Allovir, Inc. | ALVR | Conversion | Common Stock | 13.4M | $0.00 | $0 | See Footnote | 08/03/2020 |
| 07/29/2020 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 436.9k | $17.00 | $7.4M | | 07/29/2020 |
| 01/18/2011 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 540 | $82.66 | $44.6k | | 01/18/2011 |
| 11/22/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Option to Purchase Common Stock | 4k | $16.35 | $65.4k | | 11/19/2010 |
| 11/22/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 4k | $16.35 | $65.4k | | 11/19/2010 |
| 11/19/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Option to Purchase Common Stock | 20k | $13.79 | $275.8k | | 11/19/2010 |
| 11/19/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 20k | $13.79 | $275.8k | | 11/19/2010 |
| 11/19/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 20k | $75.00 | $1.5M | | 11/19/2010 |
| 09/29/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 4k | $16.35 | $65.4k | | 09/28/2010 |
| 09/28/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 20k | $13.79 | $275.8k | | 09/28/2010 |
| 09/28/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 20k | $65.01 | $1.3M | | 09/28/2010 |
| 09/28/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Option to Purchase Common Stock | 20k | $13.79 | $275.8k | | 09/28/2010 |
| 02/22/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Common Stock, par value $.0001 per share | 30k | $13.79 | $413.7k | | 02/22/2010 |
| 02/22/2010 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 30k | $50.01 | $1.5M | | 02/22/2010 |
|
|